Skip to content

MODEL4553 Micro-Pace, Dual-Chamber, Ddd Temporary Cardiac Pacemaker

by Pace Medical

PMA P920032

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P920032↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP920032 Date10 Mar 1994ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade Name
Model 4553 Dual Cham. Ddd Temp.cardiac Pacemaker
Generic Name
Generator, pulse, pacemaker, external programmable (for electrophysiological studies only)
PMA Number
FDA Product Code
JOQ
Device Class
Class II
Regulation
21 CFR Part 870.1750
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 4553 is a dual-chamber, demand-mode (DDD) temporary cardiac pacemaker designed for external use in electrophysiological studies. It delivers pacing pulses to regulate heart rhythm in patients experiencing temporary bradycardia or conduction disturbances, functioning as a pulse generator for cardiac stimulation.

This device is supplied as a reusable, externally programmable system intended for use in clinical settings such as cardiac catheterization labs or electrophysiology labs. It requires sterile electrode leads and is regulated under FDA PMA approval (P920032), classified as a Class II medical device under the product code JOQ. Storage and handling follow manufacturer guidelines to ensure proper functionality and patient safety.

Other devices from Pace Medical

See all devices from Pace Medical →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical setting where the Model 4553 is intended to be used, and why is this important for its operation?

    The Model 4553 is designed for use in controlled clinical environments like cardiac catheterization labs or electrophysiology labs. This setting is critical because it ensures proper sterile handling of electrode leads (which are required for use with this device) and allows for external programming, which is essential for temporary cardiac pacing during electrophysiological studies.

  • Is the Model 4553 a single-use or reusable device, and what does this mean for its maintenance and cost?

    The Model 4553 is a reusable device, meaning it is intended for repeated use in clinical settings after proper cleaning and maintenance. This design reduces per-patient costs compared to single-use devices and allows for consistent performance across multiple procedures, provided storage and handling follow the manufacturer’s guidelines to maintain functionality and patient safety.

  • What type of electrode leads are required for use with the Model 4553, and why is sterility important in this context?

    The Model 4553 requires sterile electrode leads for proper operation, as it is designed for temporary cardiac pacing during invasive procedures. Sterility is critical because these leads are inserted into the patient’s body, and contamination could lead to infection or compromise patient safety during electrophysiological studies or temporary bradycardia management.

  • How does the dual-chamber, demand-mode (DDD) feature of the Model 4553 benefit patients experiencing temporary heart rhythm issues?

    The dual-chamber, DDD (demand-mode) feature of the Model 4553 synchronizes pacing pulses with the patient’s natural atrial and ventricular activity. This ensures more physiologic heart rhythm regulation compared to single-chamber devices, reducing the risk of irregularities like atrial fibrillation or ventricular asynchrony during temporary bradycardia or conduction disturbances in electrophysiological studies.

  • What regulatory pathway does the Model 4553 follow, and what does this mean for healthcare providers considering its use?

    The Model 4553 follows the FDA Premarket Approval (PMA) pathway, indicated by the PMA number (P920032). This means it has undergone rigorous review by the FDA to ensure safety and effectiveness for its intended use in electrophysiological studies. Healthcare providers should confirm compliance with the manufacturer’s guidelines and storage instructions to maintain regulatory and clinical standards.